BCL2 and B-cell chronic lymphocytic leukemia: Up-regulation of prosurvival Bcl-2 family members such as Bcl-2 and Mcl-1 is associated with resistance to treatment with fludarabine, chlorambucil and rituximab, as well as shorter overall survival in CLL patients.